Literature DB >> 20643532

The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample.

Vanessa Nieratschker1, Josef Frank, Thomas W Mühleisen, Jana Strohmaier, Jens R Wendland, Johannes Schumacher, Jens Treutlein, René Breuer, Rami Abou Jamra, Manuel Mattheisen, Stefan Herms, Christine Schmäl, Wolfgang Maier, Markus M Nöthen, Sven Cichon, Marcella Rietschel, Thomas G Schulze.   

Abstract

The aim of the present study was to investigate possible associations between schizophrenia and 13 SNP markers in COMT. No association was observed in 631 cases, 207 nuclear families, and 776 controls. A cognitive performance phenotype (Trail Marking Test) was available for a subgroup of the patients. No association was found between the 13 markers and this phenotype. Four clinically-defined subgroups (early age at onset, negative symptoms, family history of schizophrenia, and life-time major depressive episode) were also investigated. Associations were observed for 3 of these subgroups, although none withstood correction for multiple testing. COMT does not appear to be a risk factor for schizophrenia in this population. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643532     DOI: 10.1016/j.schres.2010.06.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

Review 1.  [Default mode network of the brain. Neurobiology and clinical significance].

Authors:  A Otti; H Gündel; A Wohlschläger; C Zimmer; C Sorg; M Noll-Hussong
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

2.  Generation and characterization of humanized mice carrying COMT158 Met/Val alleles.

Authors:  Victoria Risbrough; Baohu Ji; Richard Hauger; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2014-02-10       Impact factor: 7.853

3.  The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.

Authors:  S A Lott; P R Burghardt; K J Burghardt; M J Bly; T B Grove; V L Ellingrod
Journal:  Pharmacogenomics J       Date:  2012-03-06       Impact factor: 3.550

4.  No association between Val158Met of the COMT gene and susceptibility to schizophrenia in the Syrian population.

Authors:  Bassam Lajin; Amal Alachkar; Abdul Rezzak Hamzeh; Roula Michati; Hamid Alhaj
Journal:  N Am J Med Sci       Date:  2011-04

5.  No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population.

Authors:  Carlos Tovilla-Zárate; Beatriz Camarena Medellín; Ana Fresán; Lilia López-Narváez; Thelma Beatriz Gonzalez Castro; Isela Juárez Rojop; Julián Ramírez-Bello; Alma Genis; Humberto Nicolini
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

6.  Investigating the genetic basis of theory of mind (ToM): the role of catechol-O-methyltransferase (COMT) gene polymorphisms.

Authors:  Haiwei Xia; Nan Wu; Yanjie Su
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

7.  The Association between COMT, BDNF, and NRG1 and Premorbid Social Functioning in Patients with Psychosis, Their Relatives, and Controls.

Authors:  Muriel Walshe; Evangelos Vassos; Marco Picchioni; Madiha Shaikh; Timothea Toulopoulou; David Collier; Colm McDonald; Robin Murray; Elvira Bramon
Journal:  Scientifica (Cairo)       Date:  2012-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.